Inulin
- Generic Name
- Inulin
- Drug Type
- Biotech
- CAS Number
- 9005-80-5
- Unique Ingredient Identifier
- JOS53KRJ01
- Background
A starch found in the tubers and roots of many plants. Since it is hydrolyzable to fructose, it is classified as a fructosan. It has been used in physiologic investigation for determination of the rate of glomerular function.
- Indication
Historically used in an important medical test of renal function, specifically a measure of glomerular filtration rate. Sometimes used to help relieve symptoms of diabetes mellitus - a condition characterised by hyperglycemia and/or hyperinsulinemia.
Oral Inulin in Combination With Fruquintinib Plus Sintilimab as Third- or Further-line Treatment in Metastatic Colorectal Cancer
- Conditions
- Metastatic Colorectal Cancer
- Interventions
- First Posted Date
- 2024-04-04
- Last Posted Date
- 2024-04-04
- Lead Sponsor
- Wuhan Union Hospital, China
- Target Recruit Count
- 30
- Registration Number
- NCT06347198
- Locations
- π¨π³
Min Jin, Wuhan, Hubei, China
Effects Of Berberine Plus Inulin On Diabetes Care in Patients With LADA
- Conditions
- Type 1 Diabetes MellitusAutoimmune Diabetes
- Interventions
- First Posted Date
- 2021-01-06
- Last Posted Date
- 2022-02-25
- Lead Sponsor
- Second Xiangya Hospital of Central South University
- Target Recruit Count
- 240
- Registration Number
- NCT04698330
- Locations
- π¨π³
Institute of Metabolism and Endocrinology, Second Xiangya Hospital, Central South University, Changsha, Hunan, China
Vitamin D and Prebiotics for Intestinal Health in Cystic Fibrosis
- Conditions
- Cystic FibrosisDysbiosis
- Interventions
- First Posted Date
- 2019-10-07
- Last Posted Date
- 2024-02-07
- Lead Sponsor
- Emory University
- Target Recruit Count
- 40
- Registration Number
- NCT04118010
- Locations
- πΊπΈ
Emory Clinic, Atlanta, Georgia, United States
Inulin for Infections in the Intensive Care Unit
- Conditions
- SepsisAntibiotic Resistant InfectionNutrition DisordersCritical IllnessNosocomial InfectionPathogen Transmission
- Interventions
- First Posted Date
- 2019-03-07
- Last Posted Date
- 2024-12-17
- Lead Sponsor
- Columbia University
- Target Recruit Count
- 94
- Registration Number
- NCT03865706
- Locations
- πΊπΈ
Columbia University Medical Center, New York, New York, United States
Evaluation of New Markers to Assess Kidney Function
- First Posted Date
- 2009-07-14
- Last Posted Date
- 2016-07-13
- Lead Sponsor
- Tufts Medical Center
- Registration Number
- NCT00938561
Effect of Elevated Plasma-Free-Fatty-Acids on Renal Hemodynamic Parameters
- Conditions
- Renal CirculationRenal Plasma FlowGlomerular Filtration RateFatty Acids, Nonesterified
- First Posted Date
- 2007-02-06
- Last Posted Date
- 2007-02-06
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 9
- Registration Number
- NCT00431665
- Locations
- π¦πΉ
Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
Atorvastatin Calcium, Oligofructose-Enriched Inulin, or Sulindac in Preventing Cancer in Patients at Increased Risk of Developing Colorectal Neoplasia
- Conditions
- Precancerous ConditionRectal CancerColon Cancer
- Interventions
- Drug: placeboOther: laboratory biomarker analysis
- First Posted Date
- 2006-06-12
- Last Posted Date
- 2017-02-15
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 85
- Registration Number
- NCT00335504
- Locations
- πΊπΈ
Mayo Clinic, Rochester, Minnesota, United States
Influence of Sulindac and Probiotics on the Development of Pouch Adenomas in Patients With Familial Adenomatous Polyposis
- Conditions
- Adenomatous Polyposis Coli
- First Posted Date
- 2006-04-27
- Last Posted Date
- 2007-08-10
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT00319007
- Locations
- π³π±
Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.